Robert Dudley
Geen lopende functies
Vermogen: 3 078 $ op 31-03-2024
Profiel
Robert Michael Dudley was the founder of TransCode Therapeutics, Inc. (founded in 2016) where he held the titles of President, Chief Executive Officer & Director until 2024, and Artemes Technologies, Inc. (founded in 2012) where he held the titles of Chairman & Chief Executive Officer until 2015.
He also worked as an Associate at Harvard Medical School from 1973 to 1975.
Dudley received his undergraduate degree from Kent State University (Ohio).
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 13-12-2023 | 4 507 ( 0.07% ) | 3 078 $ | 31-03-2024 |
Eerdere bekende functies van Robert Dudley
| Bedrijven | Functie | Einde |
|---|---|---|
| TRANSCODE THERAPEUTICS, INC. | Founder | 13-01-2024 |
| Artemes Technologies, Inc. | Chief Executive Officer | 01-10-2015 |
| Harvard Medical School | Corporate Officer/Principal | 01-12-1975 |
Opleiding van Robert Dudley
| Kent State University (Ohio) | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TRANSCODE THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
| Artemes Technologies, Inc. |
